Clinical surveillance for early stage breast cancer: An analysis of claims data Michael S. SimonMiron StanoDaryn W. Smith Report Pages: 119 - 128
Effect of a cytotoxic analog of LH-RH (T-98) on the growth of estrogendependent MXT mouse mammary cancers: Correlations between growth characteristics and EGF receptor content of tumors Karoly SzepeshaziAndrew V. SchallyAttila Nagy Report Pages: 129 - 139
Activation ofraf-1, MEK, and MAP kinase in prolactin responsive mammary cells Rina DasBarbara K. Vonderhaar Report Pages: 141 - 149
A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy Carmela RellaMaria CovielloFrancesco Schittulli Report Pages: 151 - 159
Does induction chemotherapy with a mitoxantrone/vinorelbine regimen allow a breast-conservative treatment in patients with operable locoregional breast cancer? Antoine AdenisLaurence Vanlemmenson behalf the French Northern Oncology Group Report Pages: 161 - 169
Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue He YuEleftherios P. DiamandisCarlo M. Croce Report Pages: 171 - 178
Intraoperative assessment of axillary lymph node metastases in operable breast cancer Masakuni NoguchiMasahide MinamiAkitaka Nonomura Report Pages: 179 - 185
Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors H. OlssonH. JernströmS. Rydén Report Pages: 187 - 196
Vascularity demonstrated by doppler ultrasound and immunohistochemistry in invasive ductal carcinoma of the breast Ernest E. SternsSandip SenGuptaBenny Zee Report Pages: 197 - 203
Simultaneous expression of nitric oxide synthase and estrogen receptor in human breast cancer cell lines Robert ZeillingerEva TantscherJohannes C. Huber Brief communication Pages: 205 - 207